Cargando…
Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression
Antibodies can undergo a variety of covalent and non-covalent degradation reactions that have adverse effects on efficacy, safety, manufacture and storage. We had identified an antibody to Angiopoietin 2 (Ang2 mAb) that neutralizes Ang2 binding to its receptor in vitro and inhibits tumor growth in v...
Autores principales: | Buchanan, Andrew, Clementel, Veronica, Woods, Rob, Harn, Nicholas, Bowen, Michael A, Mo, Wenjun, Popovic, Bojana, Bishop, Steven M., Dall’Acqua, William, Minter, Ralph, Jermutus, Lutz, Bedian, Vahe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893235/ https://www.ncbi.nlm.nih.gov/pubmed/23412563 http://dx.doi.org/10.4161/mabs.23392 |
Ejemplares similares
-
Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human FcγRI
por: Bonetto, Stephane, et al.
Publicado: (2009) -
Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in binding
por: Oganesyan, Vaheh, et al.
Publicado: (2015) -
Identification and quantitation of hinge cysteinylation on endogenous IgG2 antibodies from human serum
por: Ayalew, Luladey, et al.
Publicado: (2020) -
Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021) -
Enhancement of Immune Effector Functions by Modulating IgG’s Intrinsic Affinity for Target Antigen
por: Mazor, Yariv, et al.
Publicado: (2016)